Issue task order A63
Ended Awarded Last action
- Contract number
- 75N93022F00001
- Awardee
-
University Of Texas Medical Branch At Galveston UEI MSPWVMXXMN76 Part of University Of Texas System
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,676,543
Award facts
- Contract value 46% obligated
- $5,848,314.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Galveston, TX 77555, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $849,562 | |
| Exercise an Option | $825,058 | |
| Exercise an Option | $155,715 | |
| Original award | $846,208 |
About this award
This federal contract award is for a task order issued under the National Institute of Allergy and Infectious Diseases (NIAID) Preclinical Models of Infectious Diseases 2017-2024 indefinite delivery contract. The prime contractor is the University of Texas Medical Branch (UTMB) at Galveston, a state government entity and educational institution with extensive experience supporting federal agencies in areas such as infectious disease research, clinical trials, and emergency preparedness. The contract has a total ceiling value of $5,848,314.00 and an ultimate completion date of January 11, 2025. It does not have a set-aside designation. Through this task order, UTMB will provide preclinical research and development services to NIAID, a component of the National Institutes of Health, to support the evaluation of candidate therapeutics, vaccines, and diagnostics against various pathogens. As the prime contractor, UTMB leverages its high-containment research facilities and specialized expertise to rapidly respond to NIAID's evolving research needs in areas like emerging infectious diseases and antimicrobial resistance.
Quick answers
Who was awarded contract 75N93022F00001?
75N93022F00001 was awarded to University Of Texas Medical Branch At Galveston by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on November 2, 2021.
How much is contract 75N93022F00001 worth?
The government has obligated $2,676,543 on 75N93022F00001. Its current value, with exercised options, is $5,848,314.
Is contract 75N93022F00001 an order under another contract?
Yes. 75N93022F00001 is a delivery order under HHSN272201700040I, an indefinite delivery contract, on NIAID Preclinical Models of Infectious Diseases 2017-2024.
Was contract 75N93022F00001 competed?
The extent of competition for 75N93022F00001 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award